• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于掌腱膜挛缩病治疗的随机临床试验的 5 年结果:经皮针刀松解与有限筋膜切开术。

Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.

机构信息

Zwolle and Groningen, The Netherlands From the Department of Plastic, Reconstructive and Hand Surgery, Isala Clinics, and the Department of Plastic Surgery, University Medical Centre Groningen, and the University of Groningen.

出版信息

Plast Reconstr Surg. 2012 Feb;129(2):469-477. doi: 10.1097/PRS.0b013e31823aea95.

DOI:10.1097/PRS.0b013e31823aea95
PMID:21987045
Abstract

BACKGROUND

The increasing number of methods for treating Dupuytren's disease indicates a need for comparative studies. In this article, the 5-year follow-up results of a randomized controlled study that compared percutaneous needle fasciotomy and limited fasciectomy are presented.

METHODS

One hundred eleven patients with 115 affected hands with a minimal passive extension deficit of 30 degrees were assigned randomly to the two groups. Follow-up examinations were performed at 1 and 6 weeks; 6 months; and 1, 2, 3, 4, and 5 years. Outcome parameters were total passive extension deficit, patient satisfaction, flexion, and sensibility. Furthermore, disease extension was recorded. The primary endpoint was recurrence, defined as an increase of total passive extension deficit of greater than 30 degrees. Ninety-three patients reached this endpoint.

RESULTS

The recurrence rate after 5 years in the needle fasciotomy group (84.9 percent) was significantly higher than in the limited fasciectomy group (20.9 percent) (p < 0.001), and occurred significantly sooner in the needle fasciotomy group (p = 0.001). Older age at the time of treatment decreased the recurrence rate (p = 0.005). No other diathesis characteristics influenced recurrence. Patient satisfaction was high in both groups but was significantly higher in the limited fasciectomy group. Nevertheless, many patients (53 percent) preferred percutaneous needle fasciotomy in case of recurrence.

CONCLUSIONS

Percutaneous needle fasciotomy is the preferred treatment for elderly patients with Dupuytren's disease and for those willing to accept a possible early recurrence in the context of the advantages, such as fast recovery, a low complication rate, and minimal invasiveness.

CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

摘要

背景

治疗杜普伊特伦挛缩症的方法越来越多,这表明需要进行比较研究。本文报告了一项经皮针刀松解术与局限性筋膜切除术随机对照研究的 5 年随访结果。

方法

将 115 例 115 只患手(最小被动伸展度丧失 30 度)的患者随机分为两组。在 1 周和 6 周;6 个月;1 年、2 年、3 年、4 年和 5 年进行随访检查。主要的结局参数是总被动伸展缺失、患者满意度、弯曲和感觉。此外,还记录了疾病的扩展情况。主要终点是复发,定义为总被动伸展缺失增加大于 30 度。93 例患者达到了这一终点。

结果

经皮针刀松解组 5 年后的复发率(84.9%)明显高于局限性筋膜切除术组(20.9%)(p<0.001),且经皮针刀松解组的复发时间更早(p=0.001)。治疗时年龄较大的患者复发率较低(p=0.005)。其他体质特征不影响复发。两组患者的满意度均较高,但局限性筋膜切除术组的满意度明显更高。然而,许多患者(53%)在复发的情况下更喜欢经皮针刀松解术。

结论

对于老年杜普伊特伦挛缩症患者和愿意接受早期复发的患者(考虑到快速恢复、低并发症率和微创的优势),经皮针刀松解术是首选治疗方法。

临床问题/证据水平:治疗,II 级。

相似文献

1
Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.一项关于掌腱膜挛缩病治疗的随机临床试验的 5 年结果:经皮针刀松解与有限筋膜切开术。
Plast Reconstr Surg. 2012 Feb;129(2):469-477. doi: 10.1097/PRS.0b013e31823aea95.
2
Surgery for Dupuytren's contracture of the fingers.手指掌腱膜挛缩症的手术治疗
Cochrane Database Syst Rev. 2015 Dec 9;2015(12):CD010143. doi: 10.1002/14651858.CD010143.pub2.
3
Percutaneous Aponeurotomy and Lipofilling versus Limited Fasciectomy for Dupuytren's Contracture: 5-Year Results from a Randomized Clinical Trial.经皮腱膜切开术联合脂肪填充与局限性筋膜切除术治疗掌腱膜挛缩症的随机临床试验 5 年结果。
Plast Reconstr Surg. 2018 Dec;142(6):1523-1531. doi: 10.1097/PRS.0000000000004982.
4
Comparative Effectiveness of Percutaneous Needle Aponeurotomy and Limited Fasciectomy for Dupuytren's Contracture: A Multicenter Observational Study.经皮针状腱膜切开术与有限筋膜切除术治疗掌腱膜挛缩症的比较疗效:一项多中心观察性研究
Plast Reconstr Surg. 2016 Oct;138(4):837-846. doi: 10.1097/PRS.0000000000002560.
5
A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study.经皮针状筋膜切开术与局限性筋膜切除术治疗掌腱膜挛缩症的直接疗效比较:一项为期6周的随访研究。
J Hand Surg Am. 2006 May-Jun;31(5):717-25. doi: 10.1016/j.jhsa.2006.02.021.
6
A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.一项关于针状筋膜切开术与有限筋膜切除术治疗手指掌腱膜挛缩症的多中心随机对照试验的可接受性和设计的可行性研究(HAND-1):一项随机对照试验的研究方案
Trials. 2017 Aug 25;18(1):392. doi: 10.1186/s13063-017-2127-9.
7
Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy.杜普伊特伦挛缩症:经皮针状筋膜切开术与开放性筋膜切除术的疗效分析
ANZ J Surg. 2015 Sep;85(9):639-43. doi: 10.1111/ans.12513. Epub 2014 Jan 20.
8
Needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (Hand-2): study protocol for a randomised controlled trial.经皮针刀松解术与局限性筋膜切除术治疗手指挛缩症的比较(Hand-2):一项随机对照试验的研究方案。
Trials. 2024 Jun 19;25(1):398. doi: 10.1186/s13063-024-08003-1.
9
Limited fasciectomy with versus without autologous adipose tissue grafting for treatment of Dupuytren's contracture (REMEDY): study protocol for a multicentre randomised controlled trial.局限性掌腱膜切除术联合与不联合自体脂肪组织移植治疗掌腱膜挛缩症(REMEDY):一项多中心随机对照试验的研究方案。
Trials. 2024 Sep 2;25(1):577. doi: 10.1186/s13063-024-08410-4.
10
Percutaneous needle fasciotomy in dupuytren's disease.杜普伊特伦挛缩症的经皮针状筋膜切开术
J Hand Surg Br. 2006 Oct;31(5):498-501. doi: 10.1016/j.jhsb.2006.03.174. Epub 2006 Jun 12.

引用本文的文献

1
Associations of Demographic, Lifestyle, and Clinical Factors With the Presence of Dupuytren Disease: Results from the Lifelines Cohort Study.人口统计学、生活方式和临床因素与掌腱膜挛缩症的相关性:生命线队列研究结果
J Hand Surg Glob Online. 2025 Jul 24;7(5):100786. doi: 10.1016/j.jhsg.2025.100786. eCollection 2025 Sep.
2
Determining Risk Factors and Rate of Surgery After Collagenase Injections for Dupuytren Contracture.确定胶原酶注射治疗掌腱膜挛缩症后的危险因素及手术率。
J Hand Surg Glob Online. 2025 Jun 30;7(5):100768. doi: 10.1016/j.jhsg.2025.100768. eCollection 2025 Sep.
3
Outcomes of limited fasciectomy, needle fasciotomy and collagenase injection for Dupuytren's disease: a systematic review and meta-analysis of individual patient data.
掌腱膜挛缩症的有限筋膜切除术、经皮筋膜切开术和胶原酶注射治疗结果:个体患者数据的系统评价和荟萃分析
J Hand Surg Eur Vol. 2025 Jul;50(7):878-890. doi: 10.1177/17531934251338349. Epub 2025 May 20.
4
Modified percutaneous needle aponeurotomy for Dupuytren's disease: case series with functional outcome.改良经皮针腱膜切开术治疗掌腱膜挛缩症:功能结果的病例系列研究
Musculoskelet Surg. 2025 Mar 31. doi: 10.1007/s12306-025-00899-5.
5
Collagenase Clostridium Histolyticum Versus Percutaneous Needle Fasciotomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis.溶组织梭状芽胞杆菌胶原酶与经皮针状筋膜切开术治疗掌腱膜挛缩症的系统评价与Meta分析
Life (Basel). 2025 Feb 8;15(2):259. doi: 10.3390/life15020259.
6
Use of a perforator-based flap from the ulnar palmar artery for the repair of defects caused by the treatment of severe contractures due to Dupuytren's disease.使用基于尺掌动脉穿支皮瓣修复因掌腱膜挛缩症治疗导致的严重挛缩所引起的缺损。
Front Surg. 2025 Jan 23;11:1508100. doi: 10.3389/fsurg.2024.1508100. eCollection 2024.
7
Therapy for Dupuytren's Disease (II): Collagenase Therapy vs. Limited Fasciectomy-A Long-Term Comparative Study.掌腱膜挛缩症的治疗(II):胶原酶治疗与有限筋膜切除术——一项长期对比研究。
Life (Basel). 2025 Jan 10;15(1):76. doi: 10.3390/life15010076.
8
Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.英国成年患者中胶原酶注射与有限筋膜切除术治疗掌腱膜挛缩症的比较:DISC,一项非劣效性随机对照试验及经济学评估
Health Technol Assess. 2024 Dec;28(78):1-262. doi: 10.3310/KGXD8528.
9
Collagenase Versus Needle Fasciotomy for Primary Metacarpophalangeal Dupuytren Contracture: Five-Year Results from a Randomized Controlled Trial.胶原酶与经皮针式筋膜切开术治疗原发性掌指关节杜普伊特伦挛缩症:一项随机对照试验的五年结果
JB JS Open Access. 2024 Nov 20;9(4). doi: 10.2106/JBJS.OA.24.00038. eCollection 2024 Oct-Dec.
10
The presentation and treatment of Dupuytren's disease in Dutch general practitioner care.荷兰全科医生护理中掌腱膜挛缩症的临床表现与治疗
Fam Pract. 2025 Feb 7;42(2). doi: 10.1093/fampra/cmae065.